ALA to promote Lung-MAP

The American Lung Association said it will promote the Lung-MAP project, a "master protocol" trial designed to evaluate several compounds simultaneously to treat squamous cell lung cancer.

Under a partnership with the Foundation for the National Institutes of Health (FNIH), one of the protocol's designers, the ALA will promote the Phase II/III study through its Lung Force website, produce videos for investigators and patients, and sponsor meetings that include Lung-MAP leadership. ...